Increased expression of cyclooxygenase-2 in rat lung tumors induced by the tobacco-specific nitrosamine 4-(methylnitrosamino)-4-(3-pyridyl)-1- butanone: The impact of a high-fat diet

Cancer Research

Volumn 59, Issue 7, 1999, Pages 1400-1403

  El Bayoumy, Karam ^a   Iatropoulos, Michael ^a   Amin, Shantu ^a   Hoffmann, Dietrich ^a   Wynder, Ernst L ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; NITROSAMINE;

ADENOCARCINOMA; ANIMAL TISSUE; ARTICLE; CANCER GRADING; CIGARETTE SMOKING; DIETARY INTAKE; DNA DAMAGE; IMMUNOHISTOCHEMISTRY; LIPID DIET; LUNG CARCINOGENESIS; LUNG TUMOR; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION;

EID: 0033118480     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. IARC. Tobacco Smoking: IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 38. Lyon, France: IARC, 1986.
2. Wynder, E. L., and Hoffmann, D. Smoking and lung cancer: scientific challenges and opportunities. Cancer Res., 54: 5284-5295, 1994.
3. Thun, M. J., Lilly, C. A., Flannery, J. T., Calle, E. E., Flanders, W. D., and Heath, C. W. Cigarette smoking and changes in the histopathology of lung cancer. J. Natl. Cancer Inst. (Bethesda), 89: 1580-1586, 1997.
4. Stellman, S. D., Muscat, J. E., Thompson, S., Hoffmann, D., and Wynder, E. L. Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking. Cancer (Phila.), 50: 382-388, 1997.
5. Wynder, E. L. The past, present, and future of the prevention of lung cancer. Cancer Epidemiol. Biomark. Prev., 7: 735-748, 1998.
6. Hoffmann, D., and Hoffmann, I. The changing cigarette, 1950-1995. J. Toxicol. Environ. Health, 50: 307-364, 1997.
7. Hecht, S. S., and Hoffmann, D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis (Lond.), 9: 875-884, 1988.
8. Spiegelhalder, B., and Bartsch, H. Tobacco-specific nitrosamines. Eur. J. Cancer Prev., 5: 33-38, 1996.
9. Castonguay, A., Stoner, G. D., Schut, H. A. J., and Hecht, S. S. Metabolism of tobacco-specific nitrosamines by cultured human tissues. Proc. Natl. Acad. Sci. USA, 80: 6694-6697, 1993.
10. Hecht, S. S. Biochemistry, biology and carcinogenicity of tobacco-specific N-nitrosamines. Chem. Res. Toxicol., 11: 559-603, 1998.
11. Hoffmann, D., Brunnemann, K. D., Prokopczyk, B., and Djordjevic, M. V. Tobacco-specific N-nitrosamines, and areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. J. Toxicol. Environ. Health, 41: 1-52, 1994.
12. Smith, T. J., Stoner, G. D., and Yang, C. S. Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides. Cancer Res., 55: 5566-5573, 1995.
13. Rioux, N., and Castonguay, A. Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents. Carcinogenesis (Lond.), 19: 1393-1400, 1998.
14. Marnett, L. J., Reed, G. A., and Dennison, D. J. Prostaglandin synthetase-dependent activation of 7,8-dihydro-7,8-dihydroxy-benzo[a]pyrene to mutagenic derivatives. Biochem. Biophys. Res. Commun., 82: 210-216, 1978.
15. Eling, T. E., and Curtis, J. F. Xenobiotic metabolism by prostaglandin H synthase. Pharmacol. Ther., 3: 261-273, 1992.
16. Taketo, M. M. Cyclooxygenase-2 inhibitors in tumorigenesis (Part I). J. Natl. Cancer Inst. (Bethesda), 90: 1529-1536, 1998.
17. Taketo, M. M. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). J. Natl. Cancer Inst. (Bethesda), 90: 1609-1620, 1998.
18. Kelly, D. J., Mestre, J. R., Subbaramaiah, K., Sacks, P. G., Schantz, S. P., Tanabe, T., Inoue, H., Ramonetti, J. T., and Dannenberg, A. J. Benzo[a]pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells. Carcinogenesis (Lond.), 18: 795-799, 1997.
19. DuBois, R. N., Radhika, A., Reddy, B. S., and Entingh, A. J. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology, 110: 1259-1262, 1996.
20. Williams, C. S., Luongo, C., Radhika, A., Zhang, T., Lamps, L. W., Nanney, L. B., Beauchamp, R. D., and DuBois, R. N. Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gaslroenterology, 111: 1134-1140, 1996.
21. Hida, T., Yatabe, Y., Achiwa, H., Muramatsu, H., Kozaki, K-i., Nakamura, S., Ogawa, M., Mitsudomi, T., Sugiura, T., and Takahashi, T. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res., 58: 3761-3764, 1998.
22. Wolff, H., Saukkonen, K., Anttila, S., Karjalainen, A., Vainio, H., and Ristimäki, A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res., 58: 4997-5001, 1998.
23. Fujita, T., Matsui, M., Takaku, K., Uetake, H., Ichikawa, W., Taketo, M. M., and Sugihara, K. Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. Cancer Res., 58: 4823-4826, 1998.
24. Wynder, E. L., Hebert, J. R., and Kabat, G. C. Association of dietary fat and lung cancer. J. Natl. Cancer Inst. (Bethesda), 79: 631-637, 1987.
25. Goodman, M. F., Hankin, J. H., Wilkens, L. R., and Kolonel, L. N. High-fat foods and the risk of lung cancer. Epidemiology, 3: 288-299, 1992.
26. Welsch, C. W. Review of the effects of dietary fat on experimental mammary gland tumorigenesis: role of lipid peroxidation. Free Radical Biol. Med., 18: 757-773, 1995.
27. Reddy, B. S. Animal experimental evidence on macronutrients and cancer. In: M. S. Micozzi and T. E. Moon (eds.), Macronutrients, pp. 33-54. New York: Dekker, 1992.
28. Hoffmann, D. Rivenson, A., Abbi, R., and Wynder, E. L. A study of tobacco Carcinogenesis: effect of the fat content of the diet on the carcinogenic activity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. Cancer Res., 53: 2758-2761, 1993.
29. Wu, K. K. Cyclooxygenase 2 induction: molecular mechanism and pathophysiologic rates. J. Lab. Clin. Med., 128: 242-245, 1996.
30. Duperron, C., and Castonguay, A. Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice. Carcinogenesis (Lond.), 18: 1001-1006, 1997.
31. Schreinemachers, D. M., and Everson, R. B. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology, 5: 138-146, 1994.